NCT03690037View on ClinicalTrials.gov

Investigating the Effect of Intravenous and Oral Tranexamic Acid on Blood Loss After Primary Hip and Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL

Enrollment

1,089

Participants

Timeline

Start Date

July 7, 2016

Primary Completion Date

July 8, 2018

Study Completion Date

July 8, 2019

Conditions

Primary Total Knee ArthroplastyPrimary Total Hip Arthroplasty

Interventions

DRUG

Tranexamic Acid 100 MG/ML

Tranexamic Acid: 100 MG/ML Solution for injection

DRUG

Tranexamic Acid 500 MG

Tranexamic Acid: Tranexamic Acid 500mg Tablets

Trial Locations (1)

BT9 7JB

Primary Joint Unit, Musgrave Park Hospital, BHSCT, Belfast

All Listed Sponsors

lead

Belfast Health and Social Care Trust

OTHER

NCT03690037 - Investigating the Effect of Intravenous and Oral Tranexamic Acid on Blood Loss After Primary Hip and Knee Arthroplasty | Biotech Hunter | Biotech Hunter